News Archive | ||
| 16-06-2009 - Contura, Leading Permanent Filler Company, Responds to Survey by the British Association of Aesthetic Plastic Surgeons Information released last week by the British Association of Aesthetic Plastic Surgeons (BAAPS) highlighted their concerns regarding complications due to cosmetic fillers. Contura International, a Danish medical technology company that markets the permanent filler Aquamid®, ha... Read more... | ||
| 03-06-2009 - New Study Shows High Patient Satisfaction 4 Years after Correcting Facial Lipoatrophy High patient satisfaction and the long-term safety of Aquamid® was documented in the AIDS Research and Human Retroviruses journal, where the results from a new clinical study were published. In the study Aquamid was used to correct antiretroviral treatment related facial lipoat... Read more... | ||
| 18-03-2009 - Japanese clinical experience demonstrates the use of facial filler Aquamid® for nose augmentation An innovative use of Contura’s unique facial filler Aquamid®, in rhinoplasty, has been highlighted in The Journal of Plastic and Reconstructive Surgery. Over the past four years Aquamid® has been used by a group of Japanese clinicians to raise the height of the nose bridge. Thi... Read more... | ||
| 12-01-2009 - 5-year European Clinical Study presented at IMCAS Contura announced 5-year clinical data showing that more than 90% of patients and physicians are satisfied with its unique long-lasting soft tissue filler Aquamid®. The data was presented for the first time in Europe, by trial investigator Professor Norbert Pallua, at the annua... Read more... | ||
